OncoCyte Corporation
Hedge Funds Holdings
Last updated:
OncoCyte Corporation‘s stocks are currently a part of 34 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 34.75M shares of OncoCyte Corporation. Compared to the previous quarter, the number fell by -42.80% or -26.00M shares fewer. As for the holding position changes, 17.65% (6) of current hedge fund investors increased the number of shares held, 23.53% (8) of current holders sold a part of the shares held, and 11.76% (4) closed the holdings completely. 1 hedge funds are new holders of OncoCyte Corporation stock in Q1 2023, it is 2.94% of total holders.
Hedge funds holding OncoCyte (Q2 2018 – Q1 2023)
| Q2 2018 | 26 |
|---|---|
| Q3 2018 | 21 |
| Q4 2018 | 15 |
| Q1 2019 | 47 |
| Q2 2019 | 49 |
| Q3 2019 | 54 |
| Q4 2019 | 52 |
| Q1 2020 | 55 |
| Q2 2020 | 63 |
| Q3 2020 | 56 |
| Q4 2020 | 59 |
| Q1 2021 | 87 |
| Q2 2021 | 89 |
| Q3 2021 | 94 |
| Q4 2021 | 85 |
| Q1 2022 | 81 |
| Q2 2022 | 68 |
| Q3 2022 | 59 |
| Q4 2022 | 57 |
| Q1 2023 | 34 |
Hedge funds changes in OncoCyte positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 4 | 11 | 13 | -8 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 4 | 4 | 7 | 4 |
| Q4 2018 | 2 | 2 | 3 | 8 | 0 |
| Q1 2019 | 33 | 9 | 0 | 1 | 4 |
| Q2 2019 | 18 | 13 | 13 | 15 | -10 |
| Q3 2019 | 15 | 15 | 17 | 9 | -2 |
| Q4 2019 | 7 | 15 | 19 | 9 | 2 |
| Q1 2020 | 10 | 20 | 14 | 4 | 7 |
| Q2 2020 | 15 | 29 | 12 | 7 | 0 |
| Q3 2020 | 8 | 26 | 13 | 16 | -7 |
| Q4 2020 | 15 | 25 | 9 | 12 | -2 |
| Q1 2021 | 34 | 33 | 12 | 5 | 3 |
| Q2 2021 | 14 | 26 | 33 | 12 | 4 |
| Q3 2021 | 17 | 36 | 29 | 11 | 1 |
| Q4 2021 | 10 | 28 | 30 | 19 | -2 |
| Q1 2022 | 10 | 18 | 30 | 14 | 9 |
| Q2 2022 | 14 | 15 | 23 | 25 | -9 |
| Q3 2022 | 5 | 10 | 22 | 12 | 10 |
| Q4 2022 | 13 | 11 | 19 | 14 | 0 |
| Q1 2023 | 1 | 6 | 8 | 4 | 15 |
Hedge funds changes in OncoCyte stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 25,000 | 9,000 |
| Q3 2019 | 0 | 7,000 |
| Q4 2019 | 0 | 1,000 |
| Q1 2020 | 1,000 | 0 |
| Q2 2020 | 1,000 | 1,000 |
| Q3 2020 | 20,000 | 0 |
| Q4 2020 | 447,000 | 143,000 |
| Q1 2021 | 1,485,000 | 783,000 |
| Q2 2021 | 1,307,000 | 607,000 |
| Q3 2021 | 1,280,000 | 178,000 |
| Q4 2021 | 626,000 | 88,000 |
| Q1 2022 | 255,000 | 22,000 |
| Q2 2022 | 156,000 | 0 |
| Q3 2022 | 52,000 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |